Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy.

Badheka AO, Shah N, Grover PM, Patel NJ, Chothani A, Mehta K, Singh V, Deshmukh A, Savani GT, Rathod A, Panaich SS, Patel N, Arora S, Bhalara V, Coffey JO, Mitrani RD, Halperin JL, Viles-Gonzalez JF.

Am J Cardiol. 2014 Apr 1;113(7):1159-65. doi: 10.1016/j.amjcard.2013.12.021. Epub 2014 Jan 14.

PMID:
24507168
2.

Left ventricular geometry and outcomes in patients with atrial fibrillation: the AFFIRM Trial.

Apostolakis S, Sullivan RM, Olshansky B, Lip GY.

Int J Cardiol. 2014 Jan 1;170(3):303-8. doi: 10.1016/j.ijcard.2013.11.002. Epub 2013 Nov 13.

PMID:
24315343
3.

Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.

Mulder BA, Van Veldhuisen DJ, Crijns HJ, Tijssen JG, Hillege HL, Alings M, Rienstra M, Van den Berg MP, Van Gelder IC; RACE II Investigators.

Heart Rhythm. 2014 Sep;11(9):1543-50. doi: 10.1016/j.hrthm.2014.06.007. Epub 2014 Jun 9.

PMID:
24924587
4.

Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy.

Shah N, Badheka AO, Grover PM, Patel NJ, Chothani A, Mehta K, Hoosien M, Singh V, Savani GT, Deshmukh A, Rathod A, Patel N, Panaich SS, Arora S, Schwartz C, Blisker M, Coffey JO, Mitrani RD, Fuster V, Viles-Gonzalez JF.

Int J Cardiol. 2014 Jun 15;174(2):288-92. doi: 10.1016/j.ijcard.2014.04.011. Epub 2014 Apr 13.

PMID:
24794553
5.

Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.

Smit MD, Crijns HJ, Tijssen JG, Hillege HL, Alings M, Tuininga YS, Groenveld HF, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC; RACE II Investigators.

J Am Coll Cardiol. 2011 Aug 23;58(9):942-9. doi: 10.1016/j.jacc.2011.04.030.

6.

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB.

J Am Coll Cardiol. 2005 Mar 1;45(5):705-11.

7.

Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.

Saksena S, Slee A, Waldo AL, Freemantle N, Reynolds M, Rosenberg Y, Rathod S, Grant S, Thomas E, Wyse DG.

J Am Coll Cardiol. 2011 Nov 1;58(19):1975-85. doi: 10.1016/j.jacc.2011.07.036.

8.

Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.

Cadrin-Tourigny J, Wyse DG, Roy D, Blondeau L, Levesque S, Talajic M, Andrade JG, Dubuc M, Thibault B, Guerra PG, Macle L, Rivard L, Khairy P.

J Cardiovasc Electrophysiol. 2014 Dec;25(12):1306-13. doi: 10.1111/jce.12535. Epub 2014 Oct 7.

PMID:
25181386
9.

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.

Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Nieminen MS, Olsen MH, Okin PM, Palmieri V, Rokkedal JE, Devereux RB.

Blood Press. 2010 Jun;19(3):169-75. doi: 10.3109/08037051.2010.481811.

PMID:
20438307
10.

Prognostic impact of left ventricular mass severity according to the classification proposed by the American Society of Echocardiography/European Association of Echocardiography.

Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, Marino M, Modena MG.

J Am Soc Echocardiogr. 2011 Dec;24(12):1383-91. doi: 10.1016/j.echo.2011.08.012. Epub 2011 Oct 5.

PMID:
21975437
11.

Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

Haider AW, Larson MG, Benjamin EJ, Levy D.

J Am Coll Cardiol. 1998 Nov;32(5):1454-9.

12.

Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).

Groenveld HF, Tijssen JG, Crijns HJ, Van den Berg MP, Hillege HL, Alings M, Van Veldhuisen DJ, Van Gelder IC; RACE II Investigators.

J Am Coll Cardiol. 2013 Feb 19;61(7):741-8. doi: 10.1016/j.jacc.2012.11.038.

13.

Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.

Machino-Ohtsuka T, Seo Y, Ishizu T, Sugano A, Atsumi A, Yamamoto M, Kawamura R, Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Aonuma K.

J Am Coll Cardiol. 2013 Nov 12;62(20):1857-65. doi: 10.1016/j.jacc.2013.07.020. Epub 2013 Jul 31.

14.

Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.

Shariff N, Desai RV, Patel K, Ahmed MI, Fonarow GC, Rich MW, Aban IB, Banach M, Love TE, White M, Aronow WS, Epstein AE, Ahmed A.

Am J Med. 2013 Oct;126(10):887-93. doi: 10.1016/j.amjmed.2013.04.021.

15.

Lenient versus strict rate control in patients with atrial fibrillation.

Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP; RACE II Investigators.

N Engl J Med. 2010 Apr 15;362(15):1363-73. doi: 10.1056/NEJMoa1001337. Epub 2010 Mar 15.

16.

Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.

Badheka AO, Marzouka GR, Rathod AD, Patel NJ, Myerburg RJ, Mitrani RD.

Am J Cardiol. 2013 Jun 15;111(12):1759-63. doi: 10.1016/j.amjcard.2013.02.031. Epub 2013 Mar 27.

PMID:
23540545
17.

Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.

Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D'Agostino RB, Lee DS, Kannel WB, Benjamin EJ, Vasan RS.

Am J Cardiol. 2014 Jan 1;113(1):117-22. doi: 10.1016/j.amjcard.2013.09.028. Epub 2013 Oct 4.

18.

Sinus rhythm is associated with fewer heart failure symptoms: insights from the AFFIRM trial.

Guglin M, Chen R, Curtis AB.

Heart Rhythm. 2010 May;7(5):596-601. doi: 10.1016/j.hrthm.2010.01.003. Epub 2010 Jan 6.

PMID:
20159046
19.

Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.

De Schryver N, Scavée C, Marchandise S, Pasquet A, de Meester C, le Polain de Waroux JB.

Europace. 2014 Aug;16(8):1125-30. doi: 10.1093/europace/euu033. Epub 2014 Mar 5.

PMID:
24599938
20.

Supplemental Content

Support Center